Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
70
-
Total 13F shares, excl. options
-
15.3M
-
Shares change
-
-2.84M
-
Total reported value, excl. options
-
$141M
-
Value change
-
-$26.3M
-
Put/Call ratio
-
1.09
-
Number of buys
-
34
-
Number of sells
-
-37
-
Price
-
$9.27
Significant Holders of OCULAR THERAPEUTIX, INC - COMMON STOCK (OCUL) as of Q2 2017
93 filings reported holding OCUL - OCULAR THERAPEUTIX, INC - COMMON STOCK as of Q2 2017.
OCULAR THERAPEUTIX, INC - COMMON STOCK (OCUL) has 70 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.3M shares
of 159M outstanding shares and own 9.57% of the company stock.
Largest 10 shareholders include Versant Venture Management, LLC (2.22M shares), JENNISON ASSOCIATES LLC (1.99M shares), SV Health Investors, LLC (1.61M shares), BlackRock Inc. (1.38M shares), FMR LLC (1.32M shares), WELLINGTON MANAGEMENT GROUP LLP (1.31M shares), VANGUARD GROUP INC (905K shares), COLUMBUS CIRCLE INVESTORS (578K shares), MORGAN STANLEY (399K shares), and STATE STREET CORP (372K shares).
This table shows the top 70 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.